Table 2 Characteristics of pregabalin abuse among the studied group
From: Suicidal ideation and behavior among subjects with substance abuse disorder related to pregabalin
Variable | (n = 83) | ||
|---|---|---|---|
Duration (months) | Median (IQR) | 24 (12–36) | |
Maximum dose (mg) | Median (IQR) | 1500(750–1500) | |
Daily dose (mg) | Median (IQR) | 1500(750–1500) | |
Last dose since (day) | Median (IQR) | 15(4–30) | |
Variable | No | % | |
Course | Continuous | 72 | 86.7 |
Intermittent | 11 | 13.3 | |
Type of addiction | Mono | 17 | 20.5 |
Poly | 66 | 79.5 | |
Cause of abuse | Replacement of heroin | 49 | 59 |
Replacement of tramadol | 26 | 31.3 | |
For its euphoric and analgesic effect | 8 | 9.6 | |
Pain | No | 43 | 51.8 |
Yes | 40 | 48.2 | |
Urine test | −ve | 60 | 72.3 |
+ve | 23 | 27.7 | |